Evidence map›Paper›PMID 37512634›Full record

ArticleMicromachines2023

Super-Macroporous Pulluan Cryogels as Controlled Active Delivery Systems with Controlled Degradability.

Betul Ari, Mehtap Sahiner, Selin Sagbas Suner, Sahin Demirci, Nurettin Sahiner

Open access · goldAbstract read
In one paragraph

Article in Micromachines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Betul AriDepartment of Chemistry, Faculty of Science, Canakkale Onsekiz Mart University, Terzioglu Campus, 17100 Canakkale, Turkey.ORCID 0000-0003-3557-3055
Mehtap SahinerBioengineering Department, Faculty of Engineering, Canakkale Onsekiz Mart University, Terzioglu Campus, 17100 Canakkale, Turkey.ORCID 0000-0001-8666-7954
Selin Sagbas SunerDepartment of Chemistry, Faculty of Science, Canakkale Onsekiz Mart University, Terzioglu Campus, 17100 Canakkale, Turkey.ORCID 0000-0002-3524-0675
Sahin DemirciDepartment of Chemistry, Faculty of Science, Canakkale Onsekiz Mart University, Terzioglu Campus, 17100 Canakkale, Turkey.
Nurettin SahinerDepartment of Chemistry, Faculty of Science, Canakkale Onsekiz Mart University, Terzioglu Campus, 17100 Canakkale, Turkey.
Çanakkale Onsekiz Mart Üniversitesi · TR

Funding

Çanakkale Onsekiz Mart University FBA-2022-3904
6 · The paper itself

Abstract

Here, super-macroporous cryogel from a natural polysaccharide, pullulan was synthesized using a cryo-crosslinking technique with divinyl sulfone (DVS) as a crosslinker. The hydrolytic degradation of the pullulan cryogel in various simulated body fluids (pH 1.0, 7.4, and 9.0 buffer solutions) was evaluated. It was observed that the pullulan cryogel degradation was much faster in the pH 9 buffer solution than the pH 1.0 and 7.4 buffer solutions in the same time period. The weight loss of the pullulan cryogel at pH 9.0 within 28 days was determined as 31% ± 2%. To demonstrate the controllable drug delivery potential of pullulan cryogels via degradation, an antibiotic, ciprofloxacin, was loaded into pullulan cryogels (pullulan-cipro), and the loading amount of drug was calculated as 105.40 ± 2.6 µg/mg. The release of ciprofloxacin from the pullulan-cipro cryogel was investigated in vitro at 37.5 °C in physiological conditions (pH 7.4). The amount of drug released within 24 h was determined as 39.26 ± 3.78 µg/mg, which is equal to 41.38% ± 3.58% of the loaded drug. Only 0.1 mg of pullulan-cipro cryogel was found to inhibit half of the growing

Indexed as

biocompatible/degradable polysaccharide cryogelciprofloxacin releasenatural polymeric cryogel drug carrierpullulan cryogel

Identifiers

PMID37512634
PMCPMC10385955
OpenAlexW4382722320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.